AB018. Evaluation of nivolumab as second-line treatment in patients with advanced non-small cell lung cancer (NSCLC)

Asimina Nikolakopoulou, Kon/nos Tzimopoulos, Haralambos Kerasiotis, Anastasios Kallianos, Catherine Kavvada, Helen Gkartzonika, Emilia Tsarouha, Angeliki Rapti